The Journal of Heart and Lung Transplantation
Volume 27, Issue 12 , Pages 1326-1332 , December 2008

Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary Hypertension

  • Gregorio Miguel Pérez-Peñate, MD

      Affiliations

    • Pneumology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • Corresponding Author InformationReprint requests: Gregorio Miguel Pérez-Peñate, MD, Pneumology Unit, Hospital General de Gran Canaria “Dr Negrín,” Barranco de la Ballena s/n, Las Palmas de Gran Canaria 35010, Spain. Telephone: 34-928-450563. Fax: 34-928-450085
    • ,
  • Gabriel Juliá-Serdà, MD

      Affiliations

    • Pneumology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • ,
  • Nazario Ojeda-Betancort, MD

      Affiliations

    • Anesthesiology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • ,
  • Antonio García-Quintana, MD

      Affiliations

    • Vascular Radiology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • ,
  • Juan Pulido-Duque, MD

      Affiliations

    • Cardiology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • ,
  • Aurelio Rodríguez-Pérez, MD

      Affiliations

    • Anesthesiology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • ,
  • Pedro Cabrera-Navarro, MD

      Affiliations

    • Pneumology Unit, Hospital General de Gran Canaria “Dr Negrín,” Gran Canaria, Spain
    • ,
  • Miguel Angel Gómez-Sánchez, MD

      Affiliations

    • Cardiology Unit, Hospital 12 de Octubre, Madrid, Spain

Received 2 May 2008 ,Revised 30 July 2008 ,Accepted 21 August 2008.

References 

  1. In:  Rich S editors. Primary pulmonary hypertension: executive summary from the World Symposium—Primary Pulmonary Hypertension. Geneva: World Health Organization; 1998;(http://www.who.int/ncd/cvd/pph.html)
  2. Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345:1465–1471
  3. Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med. 2002;136:515–522
  4. Bonderman D, Nowotny R, Skoro-Sajer N, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest. 2005;128:2599–2603
  5. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995;75:725–748
  6. Martin R. Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study. Am J Respir Crit Care Med. 2005;17:1292–1297
  7. Channick R, Newhart J, Johnson W, et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension. Chest. 1996;109:1545–1549
  8. Barst R, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(suppl):40S–47
  9. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation. 2000;102:865–870
  10. Snow DJ, Gray SJ, Ghosh S, et al. Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth. 1994;72:185–189
  11. Vonbank K, Ziesche R, Higenbottam TW, et al. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax. 2003;58:289–293
  12. Snell GI, Salamomen RF, Bergin P, et al. Inhaled nitric oxide used as a bridge to heart–lung transplantation in a patient with end stage pulmonary hypertension. Am J Respir Crit Care Med. 1995;151:1263–1266
  13. Pérez-Peñate G, Cabrera P, Ponce M, et al. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension. Respiration. 2005;72:419–422
  14. Imanaka H, Miyano DC, Takeuchi M, et al. Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Chest. 2000;118:39–46
  15. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399–405
  16. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth. 1967;39:388–392
  17. Frampton MW, Morrow PE, Cox C, et al. Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am Rev Respir Dis. 1991;143:522–527
  18. Hugod C. Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung (A light and electron microscopic study). Int Arch Occup Environ Health. 1979;42:159–167
  19. Young JD, Dyar O, Xiong L, et al. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intensive Care Med. 1994;20:581–584
  20. Executive HS. Occupational exposure limits 1996. London: HMSO; 1996;
  21. Gerlach H, Pappert D, Lewandowski K, et al. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med. 1993;19:443–449
  22. Black SM, Sanchez LS, Mata-Greenwood E, et al. sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001;281:1051–1057
  23. Padma-Nathan H, Eardley I, Kloner RA, et al. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002;60(suppl 2):67–90
  24. Galié N, Gofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–2157
  25. Ziegler J, Ivy DD, Wigging JW, et al. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med. 1998;158:1388–1395
  26. Lepore JJ, Dec GW, Zapol WM, et al. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients. J Heart Lung Transplant. 2005;24:1950–1956
  27. Ghofrani HA, Schermuly RT, Wiedemann FR, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2003;167:1139–1141

PII: S1053-2498(08)00616-5

doi: 10.1016/j.healun.2008.08.007

The Journal of Heart and Lung Transplantation
Volume 27, Issue 12 , Pages 1326-1332 , December 2008

Article Tools

* Image Usage & Resolution